ALX Oncology Inc.

1.61
-0.19 (-10.56%)
At close: Jan 23, 2025, 3:59 PM
1.62
0.32%
After-hours Jan 23, 2025, 07:58 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Net Income -160.81M -123.48M -83.46M -45.74M -19.24M -13.73M
Depreciation & Amortization 836.00K 342.00K 51.00K 202.00K 429.00K 431.00K
Stock-Based Compensation 26.27M 23.84M 13.91M 5.44M 297.00K 269.00K
Other Working Capital 7.84M 5.34M -7.32M 3.99M 1.28M 110.00K
Other Non-Cash Items -4.96M 228.00K 5.42M 295.00K 11.00K 2.33M
Deferred Income Tax n/a n/a n/a 1.27M n/a n/a
Change in Working Capital 8.30M 9.85M -4.03M 247.00K 4.26M -159.00K
Operating Cash Flow -130.36M -89.22M -68.10M -38.29M -14.25M -13.19M
Capital Expenditures -1.27M -1.43M -4.92M -31.00K -353.00K -653.00K
Acquisitions n/a 233.99K n/a 641.00K n/a n/a
Purchase of Investments -246.63M -376.79M n/a n/a n/a n/a
Sales Maturities Of Investments 292.56M 142.80M n/a n/a n/a n/a
Other Investing Acitivies n/a -233.99K -4.26M 641.00K n/a n/a
Investing Cash Flow 44.66M -235.42M -4.92M 610.00K -353.00K -653.00K
Debt Repayment -388.00K 9.61M -281.00K -6.51M 5.92M n/a
Common Stock Repurchased n/a 336.00K 202.00K n/a n/a -6.00K
Dividend Paid n/a n/a n/a -3.00K n/a n/a
Other Financial Acitivies 792.00K 248.00K 2.75M 104.68M 9.44M 7.00K
Financial Cash Flow 59.29M 9.86M 2.47M 462.88M 15.36M 1K
Net Cash Flow -26.42M -314.78M -70.55M 425.20M 755.00K -13.84M
Free Cash Flow -131.64M -90.65M -73.02M -38.32M -14.60M -13.84M